Synthesis and Biophysical Characterization of Chlorambucil Anticancer Ether Lipid Prodrugs

Palle Jacob Pedersen, Mikkel Stochkendahl Christensen, Tristan Ruysschaert, Lars Linderoth, Thomas Lars Andresen, Fredrik Melander, Ole G. Mouritsen, Robert Madsen, Mads Hartvig Clausen

Research output: Contribution to journalJournal articlepeer-review

Abstract

The synthesis and biophysical characterization of four prodrug ether phospholipid conjugates are described. The lipids are prepared from the anticancer drug chlorambucil and have C16 and C18 ether chains with phosphatidylcholine or phosphatidylglycerol headgroups. All four prodrugs have the ability to form unilamellar liposomes (86-125 nm) and are hydrolyzed by phospholipase A2, resulting in chlorambucil release. Liposomal formulations of prodrug lipids displayed cytotoxicity toward HT-29, MT-3, and ES-2 cancer cell lines in the presence of phospholipase A2, with IC50 values in the 8-36 μM range.
Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume52
Issue number10
Pages (from-to)3408-3415
ISSN0022-2623
DOIs
Publication statusPublished - 2009

Fingerprint

Dive into the research topics of 'Synthesis and Biophysical Characterization of Chlorambucil Anticancer Ether Lipid Prodrugs'. Together they form a unique fingerprint.

Cite this